Adverse events
ADVERSE EVENT
No Serious Adverse Events were recorded. We recorded the following Adverse Events: Two participants showed reliable deterioration on the QIDS (one in monitoring, one in CBMv1), and four participants showed reliable deterioration on the GAD7 (two in monitoring, one in CBMv2, one in CBMv3). For further details of negative effects (NEQ) see the online Supplementary Results.